Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1980-7-12
|
pubmed:language |
bul
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0324-0959
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
25-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7377510-Drug Evaluation,
pubmed-meshheading:7377510-Gestational Age,
pubmed-meshheading:7377510-Humans,
pubmed-meshheading:7377510-Hyaline Membrane Disease,
pubmed-meshheading:7377510-Hydrocortisone,
pubmed-meshheading:7377510-Infant, Newborn,
pubmed-meshheading:7377510-Infant, Premature,
pubmed-meshheading:7377510-Succinates
|
pubmed:year |
1980
|
pubmed:articleTitle |
[Prevention of hyaline membrane disease with sopolkort].
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|